These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22261892)

  • 1. Is randomization to placebo safe? Risk in placebo-controlled angina trials: angina risk meta-analysis.
    Glasser SP; Willard J; Defelice A; Lawrence J; Hung J; Obot E; Girton J; Targum S; Throckmorton D; Mangano D; Lipicky RJ
    Cardiology; 2011; 120(3):174-81. PubMed ID: 22261892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranolazine (Ranexa) for chronic stable angina.
    Ndegwa S
    Issues Emerg Health Technol; 2007 Jun; (99):1-6. PubMed ID: 17595750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trials and tribulations associated with angina and traditional therapeutic approaches.
    Deedwania PC; Carbajal EV; Bobba VR
    Clin Cardiol; 2007 Feb; 30(2 Suppl 1):I16-24. PubMed ID: 18373326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease.
    Chaitman BR; Sano J
    Clin Cardiol; 2007 Feb; 30(2 Suppl 1):I25-30. PubMed ID: 18373327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
    Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA
    J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of ranolazine in patients with stable angina pectoris.
    Khera S; Kolte D; Aronow WS
    Cardiology; 2014; 128(3):251-8. PubMed ID: 24852049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
    Melloni C; Newby LK
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
    Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Murphy SA; Budaj A; Varshavsky S; Wolff AA; Skene A; McCabe CH; Braunwald E;
    JAMA; 2007 Apr; 297(16):1775-83. PubMed ID: 17456819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of myocardial ischemia.
    Sander GE; Giles TD
    Am J Geriatr Cardiol; 2005; 14(4):205-9. PubMed ID: 16015063
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
    Heidenreich PA; McDonald KM; Hastie T; Fadel B; Hagan V; Lee BK; Hlatky MA
    JAMA; 1999 May; 281(20):1927-36. PubMed ID: 10349897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
    Chaitman BR
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranolazine in patients with angina and coronary artery disease.
    Scirica BM; Morrow DA
    Curr Cardiol Rep; 2007 Jul; 9(4):272-8. PubMed ID: 17601393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
    Banon D; Filion KB; Budlovsky T; Franck C; Eisenberg MJ
    Am J Cardiol; 2014 Mar; 113(6):1075-82. PubMed ID: 24462341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic therapy of angina pectoris.
    Zavecz JH; Bueno O
    J La State Med Soc; 1995 May; 147(5):208-10, 213-6. PubMed ID: 7782675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chronic stable angina pectoris.
    Rodríguez-Ospina L; Montano-Soto L
    Bol Asoc Med P R; 2008; 100(4):39-47. PubMed ID: 19400528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranolazine: new drug. Stable angina: not worth the risk.
    Prescrire Int; 2009 Aug; 18(102):148-7. PubMed ID: 19743543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conservative therapy of patients with stable coronary heart disease].
    Custodis F; Laufs U
    Herz; 2012 Feb; 37(1):85-96. PubMed ID: 22331062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.